COST NO FEENO SET ASIDE USED.

THE CRITICAL PATH INSTITUTE - BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING

PIID: 75F40119C10135Solicitation ID: FDABAA1900123

Signed Date: Oct 30, 2025Effective Date: Sep 30, 2019End Date: Closed on Sep 29, 2025

Key Details

Dollars Obligated

$2.7M

Base & All Options

$-18,014.41

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

Food and Drug Administration

NAICS Code

541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

Product Service Code

AZ12 - R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

TUCSON, AZ, 857185893, CD-AZ-06

Description

BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING

Contractor Information

Contractor: THE CRITICAL PATH INSTITUTE

UEI: KAEPADMRKHD3

CAGE Code: 35JZ0

Location: TUCSON, AZ

Similar Awards

NCI OPERATIONAL TASK ORDER, FY26-FY27

LEIDOS BIOMEDICAL RESEARCH INC

$327.1M

MD NET

LEIDOS BIOMEDICAL RESEARCH INC

$163.5M

ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)

LEIDOS BIOMEDICAL RESEARCH INC

$141.7M

AWARD OF THE BASE TO ST. JUDE FOR CEIRR CONTRACT 75N93021C00016. THIS CONTRACT WILL SUPPORT NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE (CEIRR).

ST JUDE CHILDREN'S RESEARCH HOSPITAL INC

$103.3M

DOMESTIC INDUSTRIAL BASE EXPANSION OF KEY CHEMICALS FOR ACRYLONITRILE BUTADIENE RUBBER (NBR)

ASCEND PERFORMANCE MATERIALS TEXAS INC

$87.7M

View Full Record on USASpending.gov